# Very Severe Malaria Treated by Intravenous Artesunate

> **NCT04516317** · — · COMPLETED · sponsor: **Dr Fabrice BRUNEEL** · enrollment: 578 (actual)

## Conditions studied

- Severe Malaria

## Interventions

- **OTHER:** None (Observational study Group intravenous artesunate)
- **OTHER:** None (Observational study Group intravenous quinine)

## Key facts

- **NCT ID:** NCT04516317
- **Lead sponsor:** Dr Fabrice BRUNEEL
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-10
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-03-22
- **Target enrollment:** 578 (ACTUAL)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516317, "Very Severe Malaria Treated by Intravenous Artesunate". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04516317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*